PUBLISHER: The Business Research Company | PRODUCT CODE: 1946665
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946665
Optical coherence tomography (OCT) is a non-invasive imaging method that employs light to produce high-resolution cross-sectional images of tissues. It is predominantly utilized in ophthalmology for examining the retina and identifying various eye conditions, but it also finds uses in other medical areas for in-depth tissue imaging and evaluation. This technique offers detailed, non-invasive imaging of tissues, facilitating accurate diagnosis and monitoring of conditions in both ophthalmology and other medical disciplines.
The primary categories of optical coherence tomography (OCT) used in healthcare and life sciences include catheter-based OCT devices, Doppler OCT devices, handheld OCT devices, and tabletop OCT devices. Catheter-based OCT devices are imaging instruments employed in medical procedures that provide high-resolution images of blood vessels and internal structures during minimally invasive interventions. The technology encompasses time domain OCT (TdOCT), frequency domain OCT (FdOCT), and others, with applications across fields such as ophthalmology, cardiology, dermatology, and gastroenterology. The end users of these devices include hospitals, specialty clinics, research institutions, and more.
Tariffs are influencing the OCT for healthcare and life science market by increasing costs of imported optical components, lasers, sensors, and precision imaging modules. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are raising equipment procurement costs and delaying technology upgrades. However, they are also encouraging local assembly, regional supplier development, and innovation in cost-efficient OCT system designs.
The optical coherence tomography (oct) for healthcare and life science market research report is one of a series of new reports from The Business Research Company that provides optical coherence tomography (oct) for healthcare and life science market statistics, including optical coherence tomography (oct) for healthcare and life science industry global market size, regional shares, competitors with a optical coherence tomography (oct) for healthcare and life science market share, detailed optical coherence tomography (oct) for healthcare and life science market segments, market trends and opportunities, and any further data you may need to thrive in the optical coherence tomography (oct) for healthcare and life science industry. This optical coherence tomography (oct) for healthcare and life science market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The optical coherence tomography (oct) for healthcare and life science market size has grown rapidly in recent years. It will grow from $2.26 billion in 2025 to $2.63 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing prevalence of eye disorders, expansion of ophthalmic diagnostic procedures, technological advancements in optical imaging, growth of specialty eye clinics, early adoption in research applications.
The optical coherence tomography (oct) for healthcare and life science market size is expected to see rapid growth in the next few years. It will grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to increasing demand for point-of-care diagnostics, rising adoption in cardiology and dermatology, expansion of tele-ophthalmology services, growing investments in imaging technology innovation, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising demand for high-resolution non-invasive imaging, growing use of portable and handheld oct devices, expansion of oct applications beyond ophthalmology, enhanced integration with digital health platforms.
The increasing incidence of ocular diseases is expected to drive the growth of the optical coherence tomography (OCT) for healthcare and life science market in the coming years. Ocular diseases are conditions that affect the eyes and surrounding structures and can lead to vision impairment or blindness. The rising occurrence of these diseases is largely associated with an aging population and the growing prevalence of chronic conditions such as diabetes. Optical coherence tomography (OCT) is widely used to generate high-resolution, cross-sectional images of the retina and optic nerve, supporting the diagnosis and monitoring of various ocular conditions. For example, according to the Review of Optometry, a US-based publication providing insights and updates on eye care, approximately 80 million people worldwide are affected by glaucoma, with open-angle glaucoma (OAG) accounting for about 95% of cases. In the United States alone, more than three million individuals are currently living with the condition, and this number is projected to exceed 111 million globally by 2040. Therefore, the growing incidence of ocular diseases is expected to propel the optical coherence tomography (OCT) for healthcare and life science market.
Companies operating in the optical coherence tomography (OCT) for healthcare and life science market are focusing on the development of advanced solutions, such as multi-function ophthalmic diagnostic devices, to improve clinical efficiency. Ophthalmic diagnostic devices are designed to assess eye health and support the detection and monitoring of vision-related disorders. For instance, in July 2025, Huvitz, a South Korea-based manufacturer of ophthalmic and dental equipment, launched the OCTavius ophthalmic diagnostic device. This 5-in-1 OCT system integrates multiple eye-diagnostic functions into a single platform, reducing reliance on separate instruments. It enhances workflow efficiency by delivering rapid scans and high-quality imaging, enabling smoother clinical operations. The device captures detailed structural information of the macula and choroid, allowing comprehensive, layer-specific evaluation and supporting early disease detection and accurate clinical decision-making in ophthalmology.
In July 2024, EssilorLuxottica SA, a France-based eyewear corporation, acquired an 80% stake in Heidelberg Engineering Inc. for an undisclosed amount. This acquisition strengthens EssilorLuxottica's medical technology capabilities by incorporating advanced optical coherence tomography solutions into its clinical and diagnostic ecosystem. It also expands the company's presence in high-precision ophthalmic imaging, supporting improved patient care and clinical outcomes. Heidelberg Engineering Inc. is a Germany-based medical equipment company specializing in the development of optical coherence tomography devices for healthcare.
Major companies operating in the optical coherence tomography (oct) for healthcare and life science market are Abbott Laboratories, Canon Inc., Carl Zeiss Meditec AG, Leica Microsystems GmbH, Thorlabs Inc., Edmund Optics Inc., Huvitz Co. Ltd., Santec Corporation, Topcon Medical Systems Inc., OPTOPOL Technology SA, NinePoint Medical, Wasatch Photonics Inc., Perimeter Medical Imaging AI Inc., Nidek Co. Ltd., Novacam Technologies Inc., DermaLumics, BaySpec Inc., Imalux Corporation, Lumedica, Heidelberg Engineering GmbH
North America was the largest region in the optical coherence tomography (OCT) for healthcare and life science market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical coherence tomography (oct) for healthcare and life science market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the optical coherence tomography (oct) for healthcare and life science market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The optical coherence tomography (OCT) for healthcare and life science markets consists of revenues earned by entities by providing services such as high-resolution imaging and diagnostics for medical conditions, including device sales, maintenance, software solutions, and technical support across various medical fields such as ophthalmology, cardiology, and dermatology. The market value includes the value of related goods sold by the service provider or included within the service offering. The optical coherence tomography (OCT) for healthcare and life science markets also includes sales of imaging systems, accessories including lenses and probes, software for data analysis, and consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses optical coherence tomography (oct) for healthcare and life science market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for optical coherence tomography (oct) for healthcare and life science ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The optical coherence tomography (oct) for healthcare and life science market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.